Armune BioScience was formed to develop and commercialize high value, protein signature-based diagnostic tests for prostate, lung and breast cancers that will allow physicians and patients to make better treatment decisions.

Patents 8show all

  • 8
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 4
    C07K - Peptides
  • 4
    C12N - Microorganisms or enzymes

SEC Filings show all


7
D

Contact Information

Kalamazoo Township, MI
United States

SEC Form D Funding Events

DateOfferedSoldType
2015-01-20$8,446,261$3,537,583Equity, Security to be Acquired
2013-04-29$2,000,000$1,399,999Debt, Option to Acquire
2012-07-03$1,500,000$1,144,999Debt, Option to Acquire
2010-12-22$250,000$250,000Debt
2008-08-27Unknown Unknown Other (Paper Filing)

Key Executives

  • Donald R. Parfet
    Director
  • Eli L. Thomssen
    Executive Officer, Director
  • Gilbert Omenn
    Director
  • James Sollins
    Director
  • Dennis P. Kane
    Director
  • David A Esposito
    Executive Officer, Director
  • Donald R Parfet
    Director
  • Susan Crookston
    Executive Officer
  • Dennis P Kane
    Director